MedPath

A randomised double blind controlled study of the effects of methylphenidate on Central Audition Deficits

Completed
Conditions
Central Audition Deficit (Central Auditory Processing Disorder [CAPD])
Nervous System Diseases
Registration Number
ISRCTN35253389
Lead Sponsor
niversity of Western Ontario (Canada)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
62
Inclusion Criteria

Sixty-two consecutive attendees at a university clinic for communication disorders referred for evaluation of learning and listening problems at school by parents, teachers or family physicians and shown to have deficits of Central Audition on a Willeford standardised test battery

Exclusion Criteria

Does not match inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ot provided at time of registration.
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration.
© Copyright 2025. All Rights Reserved by MedPath